Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 70 of 97, showing 5 Applications out of 482 total, starting on record 346, ending on 350

# Protocol No Study Title Investigator(s) & Site(s)

346.

ECCT/16/10/02   PAINT Study
    A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral-naïve HIV-1 infected adolescents and children aged ≥6 to <18 years   
Principal Investigator(s)
1. Professor Walter Jaoko
Site(s) in Kenya
1. KAVI Institute of Clinical Research (Nairobi City county)
2. Kenya Medical Research Institute/Walter Reed Project, HIV Program (Kericho county)
 
View

347.

ECCT/16/10/01   INVICTUS
    INVESTIGATION OF RHEUMATIC AF TREATMENT USING VITAMIN K ANTAGONISTS, RIVAROXABAN OR ASPRIN STUDIES   
Principal Investigator(s)
1. Elijah Nyainda Ogola
2. felix ayub barasa
Site(s) in Kenya
1. Kenyatta National hospital (Nairobi City county)
2. Moi teaching and Referral Hospital (Uasin Gishu county)
3. The Karen Hospital (Nairobi City county)
 
View

348.

ECCT/16/09/03   Effect of Schistosoma mansoni infection on incidence of Plasmodium falciparum malaria among 1-5 year old children in western Kenya.
    Effect of Schistosoma mansoni infection on incidence of Plasmodium falciparum malaria among 1-5 year old children in western Kenya.   
Principal Investigator(s)
1. Dr.Pauline NM Mwinzi
Site(s) in Kenya
KEMRI CGHR
 
View

349.

ECCT/16/09/02   Monitoring Pre-Exposure Prophylaxis for Young Adult Women ( (MPYA)
    Next generation real-time monitoring for PrEP adherence in young adult women.   
Principal Investigator(s)
1. Prof. Elizabeth Anne Bukusi Bukusi
2. Dr. Stella Njuguna Njuguna
Site(s) in Kenya
1. KISUMU SITE (Kisumu county)
 
View

350.

ECCT/16/08/03   IMPAACT 2001
    A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Deborah Chepngeno Langat
Site(s) in Kenya
Kenya Medical Research Institute Walter Reed project
 
View